DEF 14A

Company

Coeptis Therapeutics Holdings, Inc.

Filed

November 14, 2024

Period of Report

December 18, 2024

Accession Number

0001683168-24-008126

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →